Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

AETHLON MEDICAL, INC.

(AEMD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/11/2021 10/12/2021 10/13/2021 10/14/2021 10/15/2021 Date
3.4(c) 3.51(c) 3.62(c) 3.56(c) 3.43(c) Last
303 351 656 352 597 598 166 516 262 131 Volume
-5.82% +3.24% +3.13% -1.66% -3.65% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 1,24 M - -
Net income 2022 -9,30 M - -
Net Debt 2022 - - -
P/E ratio 2022 -5,47x
Yield 2022 -
Sales 2023 0,55 M - -
Net income 2023 -11,2 M - -
Net Debt 2023 - - -
P/E ratio 2023 -6,73x
Yield 2023 -
Capitalization 52,8 M 52,8 M -
Capi. / Sales 2022 42,7x
Capi. / Sales 2023 96,0x
Nbr of Employees -
Free-Float 99,2%
More Financials
Company
Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the... 
More about the company
Ratings of Aethlon Medical, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about AETHLON MEDICAL, INC.
10/12AETHLON MEDICAL : Announces Peer-Reviewed Publication of Two Case Studies of Critically Il..
PR
09/22Top Premarket Gainers
MT
09/17AETHLON MEDICAL : Submission of Matters to a Vote of Security Holders (Form 8-K)
PU
09/17AETHLON MEDICAL INC : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
09/13AETHLON MEDICAL : September 2021 Aethlon Presentation for HC Wainwright Financial Conferen..
PU
09/07AETHLON MEDICAL : to Present at the H.C. Wainwright 23rd Annual Global Investment Conferen..
PR
08/13Top Premarket Gainers
MT
08/09AETHLON MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
08/09AETHLON MEDICAL INC : Results of Operations and Financial Condition, Financial Statements ..
AQ
08/09Aethlon Medical, Inc. Reports Earnings Results for the First Quarter Ended June 30, 202..
CI
07/29AETHLON MEDICAL : to Release First Quarter Financial Results and Host Conference Call on A..
PR
07/01AETHLON MEDICAL INC : Change in Directors or Principal Officers (form 8-K)
AQ
06/25AETHLON MEDICAL : HC Wainwright Adjusts Aethlon Medical's Price Target to $9 From $5, Keep..
MT
06/24AETHLON MEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
06/24Aethlon Medical, Inc. Reports Earnings Results for the Full Year Ended March 31, 2021
CI
More news
News in other languages on AETHLON MEDICAL, INC.
06/09WALL STREET STOCK EXCHANGE : Wall Street revierte tendencia y cierra con baja antes de rep..
More news
Analyst Recommendations on AETHLON MEDICAL, INC.
More recommendations
Chart AETHLON MEDICAL, INC.
Duration : Period :
Aethlon Medical, Inc. Technical Analysis Chart | AEMD | US00808Y3071 | MarketScreener
Technical analysis trends AETHLON MEDICAL, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 3,43 $
Average target price 9,33 $
Spread / Average Target 172%
EPS Revisions
Managers and Directors
Charles J. Fisher Chief Executive Officer & Director
James B. Frakes Chief Financial & Principal Accounting Officer
Edward G. Broenniman Chairman
Annette Marleau Research Director
Steven LaRosa Chief Medical Officer
Sector and Competitors